Erbstatin

Erbstatin

SCHEMBL9320673

O=CN/C=C/c1cc(O)ccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 1.00
MAPT P10636 3/20 1.00
GAA P10253 3/20 1.00
EGFR P00533 2/20 1.00
KDM4E B2RXH2 2/20 1.00
POLB P06746 1/20 1.00
PKM P14618 1/20 1.00
TDP1 Q9NUW8 1/20 1.00
L3MBTL1 Q9Y468 1/20 1.00
BACE1 P56817 2/20 0.53
MEN1 O00255 1/20 0.51
TP53 P04637 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
HPGD P15428 1/20 0.51
ALOX15 P16050 1/20 0.51
CYP2C19 P33261 1/20 0.51
KMT2A Q03164 1/20 0.51
HSD17B10 Q99714 1/20 0.51
SNCA P37840 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Erbstatin SCHEMBL9320680 1.00 ALDH1A1 (1.00) ALDH1A1MAPTGAAEGFRKDM4E
Erbstatin SCHEMBL28061341 1.00 ALDH1A1 (1.00) ALDH1A1MAPTGAAEGFRKDM4E
SCHEMBL9322706 0.85 EGFR (0.74) ALDH1A1MAPTGAAEGFRKDM4E
SCHEMBL9322697 0.85 EGFR (0.74) ALDH1A1MAPTGAAEGFRKDM4E
SCHEMBL9320662 0.82 KDM4E (0.70) ALDH1A1MAPTGAAEGFRKDM4E
SCHEMBL9320670 0.82 KDM4E (0.70) ALDH1A1MAPTGAAEGFRKDM4E
SCHEMBL10413034 0.78 MAPT (0.64) ALDH1A1MAPTGAAEGFRKDM4E
SCHEMBL9320061 0.77 MAPT (0.62) ALDH1A1MAPTGAAEGFRKDM4E
SCHEMBL9320066 0.77 MAPT (0.62) ALDH1A1MAPTGAAEGFRKDM4E
SCHEMBL9730856 0.75 MAPT (0.60) ALDH1A1MAPTGAAEGFRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4401787-B1 VECTORS TARGETING BETA-D-N-ACETYLGLUCOSAMINIDASE CENTRE NAT RECH SCIENT (FR) 2025-11-05 EP disclosed
WO-2025068340-A1 METHOD TO PREDICT AML OUTCOME Institut National de la Santé et de la Recherche Médicale (FR) 2025-04-03 WO disclosed
EP-4401787-A1 VECTORS TARGETING BETA-D-N-ACETYLGLUCOSAMINIDASE Centre National de la Recherche Scientifique (FR) 2024-07-24 EP disclosed
WO-2023041531-A1 VECTORS TARGETING BETA-D-N-ACETYLGLUCOSAMINIDASE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-03-23 WO disclosed
CN-105385011-B A kind of TPV compositions and automobile collision preventing billot 嘉兴市博尔塑胶有限公司 2018-07-31 CN disclosed
CN-105385011-A TPV composition and automobile anti-collision strip Jiaxing boer plastic co ltd 2016-03-09 CN disclosed
EP-2846788-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN Akron Molecules AG (AT) 2015-03-18 EP disclosed
WO-2013167743-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN AKRON MOLECULES GMBH (AT) 2013-11-14 WO disclosed
EP-1404659-B1 4-ARYL QUINOLS AND ANALOGS THEREOF AS THERAPEUTIC AGENTS CANCER REC TECH LTD (GB) 2010-02-10 EP disclosed
EP-1572197-B1 4- 1- (SULFONYL) -1H-INDOL-2-YL)-4- (HYDROXY) -CYCLOHEXA-2,5-DIENONE COMPOUNDS AND ANALOGS THEREOF AS THERAPEUTIC AGENTS CANCER REC TECH LTD (GB) 2009-07-29 EP disclosed
US-7307099-B2 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2007-12-11 US disclosed
US-7307099-B2 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2007-12-11 US disclosed
EP-0440887-B1 Improvement in the total synthesis of Erbstatin analogs ERBA CARLO SPA (IT) 1994-01-26 EP disclosed
US-5130472-A TOTAL SYNTHESIS OF ERBSTATIN ANALOGS FARMITALIA CARLO ERBA S.R.L. (IT) 1992-07-14 US disclosed
EP-0440887-A1 Improvement in the total synthesis of Erbstatin analogs FARMITALIA CARLO ERBA S.r.l. (IT) 1991-08-14 EP disclosed
US-4925877-A ANTITUMOR AGENTS, BACTERICIDES, ENZYME INHIBITOR ZAIDANHOJIN BISEIBUTSU KAGAKU KENKYUKAI (JP) 1990-05-15 US disclosed
EP-0238868-A2 New physiologically active substance erbstatin analogous compounds Zaidanhojin Biseibutsu Kagaku Kenkyukai (JP) 1987-09-30 EP disclosed